期刊文献+

噬菌体治疗实验性小鼠耐亚胺培南铜绿假单胞菌感染的研究 被引量:10

Application of phages in the treatment of bacteremia caused by Imipenem-resistant Pseudomonas aeruginosa
原文传递
导出
摘要 目的探讨噬菌体治疗耐药性铜绿假单胞菌感染的疗效。方法以BALB/c小鼠为实验动物,建立耐药性铜绿假单胞菌全身感染模型,应用体外试验所筛选的宽噬噬菌体进行治疗。结果噬菌体在感染复数(multipleofinfection,MOI)≥0.01时能有效杀灭铜绿假单胞菌,显著提高小鼠生存率。延迟治疗3h仍有40%的生存率。结论通过对小鼠生存率、噬菌体在体内分布及机体对噬菌体的免疫反应等指标的观察分析,噬菌体制剂简捷高效,对机体正常组织无毒副作用,从而为临床治疗全身或局部铜绿假单胞菌感染提供了新途径。 Objective To explore the effect of phage therapy for Imipenem-resistance Pseudomonas aeruginosa(IMPR-Pa) infections. Methods Phages screened out in vitro experiments are used to treat BALB/c mice from systematic infection caused by Imipenem-resistance Pseudomonas aeruginosa . Results Phages can cure all of the bacteremic mice at the MOI≥0.01. About 40% of mice survived even when the treatment was delayed for 3 hours. Conclusion Phages are effective method to control bacteria infections and have no adverse effect. It is an alternative method to control Pseudomonas infections.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2006年第5期438-441,共4页 Chinese Journal of Microbiology and Immunology
基金 武汉市科委"青年科技晨光计划"资助项目(20025001026)
关键词 动物试验 噬菌体 亚胺培南 铜绿假单胞菌 感染 Animal experiments Phage Imipenem Pseudomonas aeruginosa Infection
  • 相关文献

参考文献10

  • 1陈民钧,王辉,中国医院内病原菌耐药监测网.中国重症监护病房革兰阴性菌耐药性连续7年监测研究[J].中华医学杂志,2003,83(5):375-381. 被引量:504
  • 2Troillet N,Samore MH,Carmali Y.Imipenem-resistant Pseudomonas aeruginosa:risk factors and antibiotic susceptibility patterns.Clin InfectDis,1997,25:1094-1098.
  • 3Sambrook J,Fritsch EF,Maniatis T.Molecular cloning:a laboratory manual,2nd ed,Cold Spring Harbor Laboratory Press,Cold Spring Harbor,NY,1989,vol.1:p66-79.
  • 4Biswas B,Adhya S,Washart P,et al.Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.Infect Immun,2002,70:204-210.
  • 5Matsuzaki S,Yasuda M,Nishikawa H,et al.Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophageφ MR11.J Infect Dis,2003,187(4):613-624.
  • 6BarrowP,Lovell M,Berchieri A Jr.Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves.Clin Diagn Lab Immunol,1998,5:294-298.
  • 7Kudva IT,Jelacic S,Tarr PI,et al.Biocontrol of Escherkhia coli O157 with O157-specific bacteriophages.Appl Environ Microbiol,1999,65:3767-3773.
  • 8Lee N,Harris DL.The effect of bacteriophage treatment as a preharvest intervention strategy to reduce the rapid dissemination of Salmoaella typhimurium in pigs.Proceedings-AASV,2001,p.555-557.
  • 9Cerveny KE,DePaola A,Duckworth DH,et al.Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice.Infect Immun,2002,70:6251-6262.
  • 10Goode D,Allen VM,Barrow PA.Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages.Appl Environ Microbiol,2003,69:5032-5036.

二级参考文献10

  • 1Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 2Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 3Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 4Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 5National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 6Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.
  • 7朱戌冬,徐英春,吴伟元,王辉,陈民钧.一种新CTX-M型超广谱β-内酰胺酶及其临床意义[J].中华检验医学杂志,2001,24(4):207-210. 被引量:47
  • 8王辉,吴伟元,陈民钧.肠杆菌科细菌中超广谱β-内酰胺酶(ESBL)的研究[J].中华微生物学和免疫学杂志,2001,21(6):676-679. 被引量:100
  • 9佘丹阳,刘又宁.AmpC酶和超广谱β-内酰胺酶在阴沟肠杆菌中的表达及对其耐药性的影响[J].中华医学杂志,2002,82(19):1355-1358. 被引量:86
  • 10吴伟元,陈民钧,王辉.阴沟肠杆菌6株中产超广谱β内酰胺酶的基因型[J].中国抗感染化疗杂志,2001,1(3):155-159. 被引量:15

共引文献503

同被引文献79

引证文献10

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部